Orthofix Medical Inc

Orthofix Medical insider sales are routine tax‑cover moves, yet the firm’s strong clinical trials and FDA clearances suggest long‑term growth, reassuring investors and clinicians alike.

Engine Capital’s disciplined 6%+ stake in Orthofix signals a bullish micro‑signal—despite recent price dips, the firm’s strong earnings outlook may prompt a valuation reset.